Back
Crown Holdings 10K Form
Sell
48
CCK
Crown Holdings
Last Price:
93.89
Seasonality Move:
8.21%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-10-30 | 10Q | CCK/Crown Holdings Quarterly |
2023-07-28 | 10Q | CCK/Crown Holdings Quarterly |
2023-04-28 | 10Q | CCK/Crown Holdings Quarterly |
2022-11-01 | 10Q | CCK/Crown Holdings Quarterly |
2022-08-01 | 10Q | CCK/Crown Holdings Quarterly |
2022-04-29 | 10Q | CCK/Crown Holdings Quarterly |
Receive CCK News And Ratings
See the #1 stock for the next 7 days that we like better than CCK
CCK Financial Statistics
Sales & Book Value
Annual Sales: | $12.01B |
---|---|
Cash Flow: | $478M |
Price / Cash Flow: | 10.35 |
Annual Sales: | $21.16 |
Price / Book: | 4.44 |
Profitability
EPS (TTM): | 0.81000 |
---|---|
Net Income (TTM): | $98M |
Gross Margin: | $2.46B |
Return on Equity: | 3.35% |
Return on Assets: | 0.66% |
Crown Holdings Earnings Forecast
Key Crown Holdings Financial Ratios
- The Gross Profit Margin over the past 40 years for CCK is 20.52%.
- The Selling, General & Administrative Expenses for CCK have been equal to 4.85% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 96.89% of Operating Income.
- The Net Earning history of CCK is 3.75% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 23 years.
Crown Holdings Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Containers & Packaging |
Sector: | Materials |
Current Symbol: | CCK |
CUSIP: | 228368 |
Website: | crowncork.com |
Debt
Debt-to-Equity Ratio: | 2.97 |
---|---|
Current Ratio: | 1.21 |
Quick Ratio: | 0.78 |
Price-to-Earnings
Trailing P/E Ratio: | 24.97 |
---|---|
Forward P/E Ratio: | 13.61 |
CCK Technical Analysis vs Fundamental Analysis
Sell
48
Crown Holdings (CCK)
is a Sell
Is Crown Holdings a Buy or a Sell?
-
Crown Holdings stock is rated a Sell
The current Crown Holdings [CCK] share price is $93.90. The Score for CCK is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.